SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-025457
Filing Date
2018-01-30
Accepted
2018-01-30 16:12:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(5) d517525d424b5.htm 424B5 384444
2 GRAPHIC g517525g73a92.jpg GRAPHIC 25606
  Complete submission text file 0001193125-18-025457.txt   421003
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222372 | Film No.: 18559226
SIC: 2834 Pharmaceutical Preparations